|
AMGN
|
Amgen Inc.
|
US
|
NASDAQ
|
|
ANNX
|
Annexon, Inc.
|
US
|
NASDAQ
|
|
APGN
|
Apexigen, Inc.
|
US
|
NASDAQ
|
|
ARDS
|
Aridis Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ATNM
|
Actinium Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
ATXS
|
Astria Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BCEL
|
Atreca, Inc.
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
|
CGEN
|
Compugen Ltd.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CMMB
|
ChemomAb Therapeutics Ltd.
|
US
|
NASDAQ
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
EBS
|
Emergent Biosolutions, Inc.
|
US
|
NYSE
|
|
ELEV
|
Elevation Oncology, Inc.
|
US
|
NASDAQ
|
|
EQ
|
Equillium, Inc.
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
US
|
NASDAQ
|
|
FSTX
|
F-star Therapeutics, Inc.
|
US
|
NASDAQ
|